TORTOLA, British Virgin Islands–(BUSINESS WIRE)–Juvenescence, a life sciences company developing therapeutics and technologies to treat diseases of ageing and increase human longevity, announces that David Ellam has joined its Executive Management Team as Chief Financial Officer. David has almost 20 years of experience within life science companies. He has previously occupied several senior finance roles within both US & UK publicly owned life science companies, most recently as CFO at Si

Source link